A finger-prick blood test can accurately identify p-tau217 — a key biomarker of Alzheimer's disease (AD) — without the need for temperature or storage control measures. In a pilot study, researchers ...
AUSTIN, TX / ACCESS Newswire / March 31, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced a ...
The company that aims to succeed where Theranos failed just achieved a critical milestone ahead of bringing its BetterWay blood testing service to market next year. FDA recently cleared the BD ...
Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.
In some embodiments, the method comprises providing a first low volume, capillary blood sample (or any low volume blood sample and/or any blood sample not obtained from a vein or by venipuncture) ...
Hims & Hers Health, Inc. (NYSE: HIMS) on Wednesday agreed to acquire YourBio Health, Inc., a Boston-based provider of capillary whole blood sampling technology. YourBio Health develops technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results